The Systemic Immune Response to Collagen-Induced Arthritis and the Impact of Bone Injury in Inflammatory Conditions.
José H TeixeiraAndreia M SilvaMaria Inês AlmeidaMafalda Bessa-GonçalvesCarla CunhaMário A BarbosaSusana Gomes SantosPublished in: International journal of molecular sciences (2019)
Rheumatoid arthritis (RA) is a systemic disease that affects the osteoarticular system, associated with bone fragility and increased risk of fractures. Herein, we aimed to characterize the systemic impact of the rat collagen-induced arthritis (CIA) model and explore its combination with femoral bone defect (FD). The impact of CIA on endogenous mesenchymal stem/stromal cells (MSC) was also investigated. CIA induction led to enlarged, more proliferative, spleen and draining lymph nodes, with altered proportion of lymphoid populations. Upon FD, CIA animals increased the systemic myeloid cell proportions, and their expression of co-stimulatory molecules CD40 and CD86. Screening plasma cytokine/chemokine levels showed increased tumor necrosis factor-α (TNF-α), Interleukin (IL)-17, IL-4, IL-5, and IL-12 in CIA, and IL-2 and IL-6 increased in CIA and CIA+FD, while Fractalkine and Leptin were decreased in both groups. CIA-derived MSC showed lower metabolic activity and proliferation, and significantly increased osteogenic and chondrogenic differentiation markers. Exposure of control-MSC to TNF-α partially mimicked the CIA-MSC phenotype in vitro. In conclusion, inflammatory conditions of CIA led to alterations in systemic immune cell proportions, circulating mediators, and in endogenous MSC. CIA animals respond to FD, and the combined model can be used to study the mechanisms of bone repair in inflammatory conditions.
Keyphrases
- rheumatoid arthritis
- immune response
- bone mineral density
- oxidative stress
- bone marrow
- disease activity
- lymph node
- mesenchymal stem cells
- drug induced
- soft tissue
- stem cells
- high glucose
- diabetic rats
- poor prognosis
- bone loss
- signaling pathway
- ankylosing spondylitis
- mass spectrometry
- early stage
- systemic lupus erythematosus
- endothelial cells
- acute myeloid leukemia
- interstitial lung disease
- high resolution
- bone regeneration
- rectal cancer
- sentinel lymph node
- neoadjuvant chemotherapy
- idiopathic pulmonary fibrosis